MAIA Biotechnology, Inc.
MAIA
$2.48
$0.145.98%
AMEX
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 42.91% | 43.88% | -96.29% | -95.96% | -36.12% |
Total Depreciation and Amortization | -- | -- | -- | -- | -- |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -141.81% | -203.81% | 564.49% | 567.37% | 39.04% |
Change in Net Operating Assets | -75.23% | -101.32% | -223.81% | -182.14% | 35.32% |
Cash from Operations | 2.11% | -11.64% | -82.96% | -6.73% | -35.35% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -12.13% | 49,228.57% | 44.48% | -- | 30,867.76% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 79.08% | -151.24% | 80.35% | -- | -203.79% |
Cash from Financing | -3.58% | 397.86% | 93.89% | -- | 2,705.18% |
Foreign Exchange rate Adjustments | -304.58% | 191.18% | 440.00% | -137.50% | -56.19% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -12.96% | 5.03% | 112.07% | 133.31% | 133.61% |